A sodium channel gene SCN9A polymorphism that increases nociceptor excitability

Annals of Neurology

Volumn 66, Issue 6, 2009, Pages 862-866

  Estacion, Mark ^a,b   Harty, T Patrick ^a,b   Choi, Jin Sung ^a,b   Tyrrell, Lynda ^a,b   Dib Hajj, Sulayman D ^a,b   Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL;

ARTICLE; CHROMOSOME; CONTROLLED STUDY; DEPOLARIZATION; ERYTHROMELALGIA; ETHNICITY; GENE EXPRESSION; HUMAN; MEMBRANE CHANNEL; MEMBRANE POTENTIAL; NERVE CELL; NERVE EXCITABILITY; NOCICEPTION; NOCICEPTIVE RECEPTOR; PAIN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL GANGLION;

ANIMALS; ARGININE; BIOPHYSICAL PHENOMENA; CELL LINE, TRANSFORMED; ELECTRIC STIMULATION; GANGLIA, SPINAL; GREEN FLUORESCENT PROTEINS; HUMANS; MEMBRANE POTENTIALS; MICE; NOCICEPTORS; PATCH-CLAMP TECHNIQUES; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSORY RECEPTOR CELLS; SENSORY THRESHOLDS; SODIUM CHANNELS; TRANSFECTION; TRYPTOPHAN;

EID: 73549101494     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21895     Document Type: Article

References (20)

1. Toledo-Aral JJ, Moss BL, He ZJ, et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci U S A 1997; 94:1527-1532.
2. Djouhri L, Newton R, Levinson SR, et al. Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel alpha subunit protein. J Physiol 2003;546:565-576.
3. Waxman SG. A channel sets the gain on pain. Nature 2006; 444:831-832.
4. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG. From genes to pain: Na v 1.7 and human pain disorders. Trends Neurosci 2007;30:555-563.
5. Drenth J, Waxman SG. Mutations in sodium channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest 2007;177:3603-3609.
6. Fertleman CR, Baker MD, Parker KA, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006;52: 767-774.
7. Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006;444:894-898.
8. v1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive DRG neurons. J Neurosci 2006;26:12566-12575.
9. Klugbauer N, Lacinova L, Flockerzi V, Hofmann F. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 1995;14:1084-1090.
10. v1.7 sodium channels in spinal sensory neurons. J Physiol 2003; 551(pt 3):741-750.
11. v1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci 2008;28:11079-11088.
12. Dib-Hajj SD, Rush AM, Cummins TR, et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 2005;128:1847-1854.
13. Rush AM, Dib-Hajj SD, Liu S, et al. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A 2006;103:8245-8250.
14. v1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. J Physiol 2007;581:1019-1031.
15. +-ATPase activity. J Neurosci 1994;14:2464-2475.
16. + conductance in rat optic nerve axons. Proc Natl Acad Sci U S A 1993;90:6976-6980.
17. Han C, Dib-Hajj SD, Lin Z, et al. Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation. Brain 2009;132:1711-1722.
18. Djouhri L, Koutsikou S, Fang X, et al. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci 2006; 26:1281-1292.
19. Drenth JPH, te Morsche RHM, Guillet G, et al. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage-gated sodium channels. J Invest Dermatol 2005;124: 1333-1338.
20. Howell VM, Jones JM, Bergren SK, et al. Evidence for a direct role of the disease modifier SCNM1 in splicing. Hum Mol Genet 2007;16:2506-2516.